Microcurrent for Healing Autogenous Skin Donor Sites

NCT ID: NCT00558701

Last Updated: 2016-06-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-12-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This single-center, prospective, randomized, and controlled study evaluated the efficacy of silver-coated dressing with active microcurrent in comparison to silver-coated dressing with sham microcurrent on wound-closure time for autogenous skin donor sites.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The specific aims of the study are to evaluate the impact of active versus sham direct microcurrent application to silver nylon dressings in the treatment of donor sites for partial thickness thermal injuries. The primary endpoint is wound-closure time (re-epithelialization of 90% or more of wound surface). A secondary endpoint was infection. Exploratory assessments of clinical outcomes, including inflammation, and pain medication (type, dosage, route, timing) will also be conducted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burns

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Microcurrent Stimulator + Silverlon

Patients receiving active electrical stimulation (15-50 microamps) during treatment of skin donor sites with Silverlon wound contact dressing. Intervention is active electrical stimulation via microcurrent stimulator.

Group Type ACTIVE_COMPARATOR

Microcurrent stimulator

Intervention Type DEVICE

Microcurrent stimulation from 15-50 microamps

Silverlon Wound Contact Dressing

Intervention Type DEVICE

Silver coated nylon dressing FDA approved for use on donor sites in burn patients

Silverlon alone

Patients receiving treatment of skin donor sites with Silverlon wound contact dressing alone (i.e., without active electrical stimulation)

Group Type SHAM_COMPARATOR

Silverlon Wound Contact Dressing

Intervention Type DEVICE

Silver coated nylon dressing FDA approved for use on donor sites in burn patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Microcurrent stimulator

Microcurrent stimulation from 15-50 microamps

Intervention Type DEVICE

Silverlon Wound Contact Dressing

Silver coated nylon dressing FDA approved for use on donor sites in burn patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between 18-65 years of age
* burn less than 30% total body surface area
* burns not involving donor site area
* you need skin grafting to cover burns
* agree not to use other electronic devices that generate current during your study participation
* agree to come back for follow up visits at least every other day after discharge from hospital until donor site is healed

Exclusion Criteria

* you have an illness that may affect how your wound heals such as diabetes, blood clotting disorder, cirrhosis, liver failure, peripheral vascular disease
* you are taking medications that could affect how your wound heals such as steroids, Plavix, Coumadin
* you have an infection of the skin or your bloodstream
* you are pregnant or nursing
* you are sensitive or allergic to silver or nylon
* your burn wounds are more than 30% of your total body surface area
* your site was previously harvested for grafting
* you have an implantable pacemaker device
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samueli Institute for Information Biology

OTHER

Sponsor Role collaborator

United States Army Institute of Surgical Research

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leopoldo C Cancio, MD

Role: PRINCIPAL_INVESTIGATOR

United States Army Institute of Surgical Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

USAISR

Fort Sam Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Kauvar DS, Cancio LC, Wolf SE, Wade CE, Holcomb JB. Comparison of combat and non-combat burns from ongoing U.S. military operations. J Surg Res. 2006 May 15;132(2):195-200. doi: 10.1016/j.jss.2006.02.043. Epub 2006 Mar 31.

Reference Type BACKGROUND
PMID: 16580688 (View on PubMed)

Malin EW, Galin CM, Lairet KF, Huzar TF, Williams JF, Renz EM, Wolf SE, Cancio LC. Silver-coated nylon dressing plus active DC microcurrent for healing of autogenous skin donor sites. Ann Plast Surg. 2013 Nov;71(5):481-4. doi: 10.1097/SAP.0b013e31829d2311.

Reference Type DERIVED
PMID: 23903090 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I.2007.128

Identifier Type: OTHER

Identifier Source: secondary_id

H-07-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

New Treatment for Donor Sites
NCT00591916 WITHDRAWN PHASE2/PHASE3
Microsurfaced Grafts in Deep Burn Wounds
NCT04589442 RECRUITING PHASE4